Name

Ownership

State of Incorporation

Enteron Pharmaceuticals, Inc.

100.00

%

Delaware

Orasomal Technologies Inc.

75.30

%

Delaware

Soligenix BioPharma Canada Incorporated

100.00

%

Canada

Soligenix UK Limited

100.00

%

United Kingdom

Soligenix NE B.V.

​

100.00

%

Netherlands

Soligenix Biopharma HI, Inc.

​

100.00

%

Hawaii